Navigation Links
NeuroVive Appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors
Date:3/18/2013

o of products to treat acute cardiovascular and neurological conditions through mitochondrial protection.

NeuroVive's products are based on the cyclophilin inhibitor cyclosporine and work by preventing the death of mitochondria in distressed cells and the subsequent cascade of intracellular biochemical events that lead to secondary tissue damage following an acute cardiac or traumatic brain injury.

NeuroVive's lead product is CicloMulsion®, the first cyclophilin inhibitor for the treatment of reperfusion injuries following stenting. CicloMulsion® is currently in a 1000 patient Phase III clinical trial evaluating its ability to reduce reperfusion injuries in patients with myocardial infarction.

NeuroVive is also developing NeuroSTAT®, a cyclophilin inhibitor, which is soon expected to enter a Phase IIa clinical trial in patients with severe traumatic brain injury. Both indications have huge medical need and for which there are currently no approved pharmaceutical treatment options. Both CicloMulsion® and NeuroSTAT® are special formulations of cyclosporine for use in acute cardiac and brain injury indications.

NeuroVive's pipeline includes novel cyclophilin inhibitors, and drug candidates that act on mitochondria to address energy regulation disorders.

NeuroVive´s shares are listed on the Swedish trading platform AktieTorget (http://www.aktietorget.se). The AktieTorget market is focused on emerging, entrepreneurial businesses through an electronic trading system supplied by the OMX Nordic stock exchange in Stockholm, Sweden.

Media and investor relations contacts

NeuroVive Pharmaceutical: Mikael Bronnegard
Email: info@neurovive.com
Phone No: +46(0)70-299-62-64

Citigate Dewe Rogerson: Nina Enegren / David Dible
'/>"/>

SOURCE NeuroVive Pharmaceutical AB
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cellular Biomedicine Group Appoints Dr. Jianping Dai to the Board of Directors
2. PCI Appoints John Davis, PE, to Board
3. California Healthcare Institute Appoints Vice President-State Government Affairs
4. Clinical Immunology Society Appoints Vincent Bonagura, MD as Editor-in-Chief of the Journal of Clinical Immunology
5. Quadrant Engineering Plastic Products Appoints a New England Territorial Manager and Production Supervisor
6. Creabilis Appoints Catherine Moukheibir to its Board of Directors
7. Verenium Appoints Holger Liepmann To Its Board Of Directors
8. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
9. Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D
10. Avantium Appoints Jonathan Wolfson to its Supervisory Board
11. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Sterlitech Corporation introduces the ... line of analytical laboratory equipment. With optimized features, such as PTFE-coated contact surfaces, ... resistant and maintenance-free solution for a broad range of vacuum filtration applications. , ...
(Date:7/31/2015)... , July 31, 2015 China Cord ... China,s leading provider of cord blood ... cell storage services, today announced that the Company has ... U.S. Securities and Exchange Commission. The filed Form 20-F ... March 31, 2015. The Form 20-F can be accessed ...
(Date:7/30/2015)... ATLANTA , July 30, 2015 ... leaders to the 2015 AACC Annual Meeting & ... from July 26–30. The meeting showcased revolutionary ... improves the ability of healthcare providers to diagnose ... get effective medical treatment. As ...
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report on ... current state of the global Propanol market with a focus on the Chinese situation. ... Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang ...
Breaking Biology Technology:Sterlitech Launches New Line of Vacuum Pumps 2China Cord Blood Corporation Files Its Annual Report on Form 20-F 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3
... SAN FRANCISCO, May 5, 2011 Boston Scientific Corporation ... an analysis of its ALTITUDE ® Clinical Science ... lethal arrhythmias without an increase in mortality due to ... risk associated with these shocks is not attributed to ...
... 2011 AlloSource, a leading developer, processor, ... in surgical procedures around the world, broke ground today ...  The construction project, designed by Intergroup Architects and built ... than half of the existing facility. "From ...
... May 5, 2011 Caliper Life Sciences, Inc. (NASDAQ: ... and services for drug discovery and life sciences research ... Group (COG 2011) meeting on May 17th and 18th. ... drug discovery, and diagnostics to discuss the technologies and ...
Cached Biology Technology:ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock 2ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock 3ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock 4AlloSource Starts Construction on New Campus 2AlloSource Starts Construction on New Campus 3Caliper Owners Group and Investor Meeting to Highlight Technologies Enabling Personalized Medicine 2
(Date:7/20/2015)... -- Acuity Market Intelligence,s latest research "The Global Biometrics ... Privacy" forecasts that between 2014 and 2020 nearly ... to smart mobile devices by 2.2 billion mobile ... to generate more than $67.9 billion in total ...    "Biometrics is at the center ...
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the fourth quarter ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
Breaking Biology News(10 mins):Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... This news release is available in German ... are evidently much more specific than previously assumed. More precise tests ... future. This is the result of studies carried out by the ... the Haukeland University Hospital in Bergen. The researchers examined patients with ...
... NEW YORK, NY - December 10, 2013 Researchers ... a virulent new strain of influenza the virus that causes ... disease in humans even after it develops resistance to antiviral medications. ... in the journal Nature Communications . It is ...
... Sirtuin family of protein deacylases has received considerable attention ... diabetes, cancer, and metabolic regulation. In a new study ... Cell Metabolism , Buck Institute researchers have now identified ... mitochondrial sirtuin, SIRT5. Using a novel quantitative proteomic ...
Cached Biology News:Each food fish can cause specific allergies 2Each food fish can cause specific allergies 3Mount Sinai researchers say new strain of bird flu packs a punch even after becoming drug-resistant 2SIRT5 regulation has dramatic effect on mitochondrial metabolism 2SIRT5 regulation has dramatic effect on mitochondrial metabolism 3
Ezrin/Radixin/Moesin Antibody...
Rabbit Anti-conjugated Agmatine Polyclonal Antibody...
ABCA1 Immunogen: Mouse ABCA1-expressing HeLa stable transfectants. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... ( Abpromise for all tested ... Synthetic peptide based on the propeptide ... amino acid sequence is proprietary) ... SWISS Protein ID: ...
Biology Products: